RR

Rajesh Rajendraprasad Chaudhary

Active Director Additional Director DIN 11418527
DIN 11418527 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Rajendraprasad Chaudhary

Data last updated:

Rajesh Rajendraprasad Chaudhary is an Additional Director at Mooncure Diabetes Private Limited (since 2025).

DIN 11418527
Primary Designation Additional Director
First Appointment 12 Dec 2025
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mooncure Diabetes Private Limited U86909CH2023PTC045311
Additional Director12 Dec 20252023Active

Board colleagues of Rajesh Rajendraprasad Chaudhary

Directorship timeline

Open interactive timeline →
Mooncure Diabetes Private Limited
Premium access

Shareholding and investment profile for Rajesh Rajendraprasad Chaudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Rajendraprasad Chaudhary

Rajesh Rajendraprasad Chaudhary currently holds 1 directorship: Mooncure Diabetes Private Limited (Additional Director, since 12 Dec 2025).

Rajesh Rajendraprasad Chaudhary was first appointed on 12 Dec 2025 as Additional Director at Mooncure Diabetes Private Limited.

The current boards of Rajesh Rajendraprasad Chaudhary's companies include Amit Khokhar (Mooncure Diabetes Private Limited), Santosh Kumar Ray (Mooncure Diabetes Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available